Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia

Chest

Volumn 136, Issue 3, 2009, Pages 823-831

  Huang, David T ^a,b   Angus, Derek C ^a,b   Kellum, John A ^a,b   Pugh, Nathan A ^a   Weissfeld, Lisa A ^a   Struck, Joachim ^c   Delude, Russell L ^a,b   Rosengart, Matthew R ^a,b   Yealy, Donald M ^a,b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROADRENOMEDULLIN; PROCALCITONIN; UREA;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREATHING RATE; CALCITONIN BLOOD LEVEL; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONFUSION; DEATH; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; STRATIFICATION; SYSTOLIC BLOOD PRESSURE; TEACHING; THORAX RADIOGRAPHY; UREA BLOOD LEVEL;

EID: 70049112524     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-1981     Document Type: Article

References (25)

1. Struck J, Tao C, Morgenthaler NG, et al. Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. Peptides 2004; 25:1369-1372 (Pubitemid 39180069)
2. Beltowski J, Jamroz A. Adrenomedullin: what do we know 10 years since its discovery? Pol J Pharmacol 2004; 56:5-27
3. Itoh T, Obata H, Mmurakami S, et al. Adrenomedullin ameliorates lipopolysaccharide-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 2007; 293:L446-L452 (Pubitemid 47205025)
4. Temmesfeld-Wollbruck B, Brell B, David I, et al. Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock. Intensive Care Med 2007; 33:703-710 (Pubitemid 46474908)
5. Shindo T, Kurihara H, Maemura K, et al. Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 2000; 101:2309-2316 (Pubitemid 30317135)
6. Nishio K, Akai Y, Murao Y, et al. Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med 1997; 25:953-957 (Pubitemid 27264238)
7. Ueda S, Nishio K, Minamino N, et al. Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med 1999; 160:132-136 (Pubitemid 29326078)
8. Christ-Crain M, Morgenthaler NG, Stolz D, et al. Proadrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTNO4176397]. Crit Care 2006; 10:R96 (Pubitemid 47086829)
9. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250 (Pubitemid 27044625)
10. Huang DT, Weissfeld LA, Kellum JA, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008; 52:48-58
11. Morgenthaler NG, Struck J, Alonso C, et al. Measurement of midregional proadrenomedullin in plasma with an immuno-luminometric assay. Clin Chem 2005; 51:1823-1829 (Pubitemid 41368172)
12. Khan SQ, O'Brien RJ, Struck J, et al. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 2007; 49:1525-1532 (Pubitemid 46517963)
13. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58:377-382 (Pubitemid 36560938)
14. Eto T, Kitamura K, Kato J. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin Exp Pharmacol Physiol 1999; 26:371-380 (Pubitemid 29306952)
15. Gegenhuber A, Struck J, Dieplinger B, et al. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J Card Fail 2007; 13:42-49 (Pubitemid 46343794)
16. Nishida H, Horio T, Suzuki Y, et al. Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin. Peptides 2008; 29:599-605
17. Stolz D, Christ-Crain M, Morgenthaler NG, et al. Plasma pro-adrenomedullin but not plasma pro-endothelin predicts survival in exacerbations of COPD. Chest 2008; 134:263-272
18. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-1754 (Pubitemid 32578779)
19. Richter SS, Beekmann SE, Croco JL, et al. Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithm. J Clin Microbiol 2002; 40:2437-2444
20. Weinstein MP, Murphy JR, Reller LB, et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults; II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis 1983; 5:54-70
21. Metersky ML, Ma A, Bratzler DW, et al. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169:342-347 (Pubitemid 38134812)
22. Graham JC, Galloway A. ACP Best Practice No 167: the laboratory diagnosis of urinary tract infection. J Clin Pathol 2001; 54:911-919
23. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community-acquired pneumonia in adults: Infectious Diseases Society of America. Clin Infect Dis 2000; 31:347-382
24. Mayhall CG. Hospital epidemiology and infection control. Philadelphia, PA: Lippincott Williams & Wilkins, 2004; 1659-1702
25. Granato PA. Pathogenic and indigenous microorganisms of humans. In: Murray PR, ed. Manual of clinical microbiology. Washington, DC: American Society for Microbiology Press, 2003; 44-54